Oncoguard Liver
Blood-based aid for HCC detection in an at-risk surveillance population.
- Developer
- Exact Sciences
- Intended use
- Early Detection
- Cancer scope
- Hepatocellular carcinoma
- Specimen
- Whole blood-derived plasma/serum
- Molecular modality
- Multi-omics
- Current version
- Current commercial Oncoguard Liver configuration
- Evidence context
- 2 structured studies · 9 indexed performance results · 4 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.